Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Darbepoetin Alfa Treatment Upon the Rehabilitation Following Planned Surgery for Colorectal Cancer

NCT00122720 is registered in ClinicalTrials.gov with Herning Hospital as lead sponsor.

NCT NCT00122720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Darbepoetin Alfa Treatment Upon the Rehabilitation Following Planned Surgery for Colorectal Cancer
Lead sponsor
Herning Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2003
Completion date
January 31, 2006
Enrollment
200
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer